Search Results - "DOVAL, Dinesh"

Reduced graphene oxide modified smart conducting paper for cancer biosensor by Kumar, Saurabh, Kumar, Suveen, Srivastava, Saurabh, Yadav, Birendra K., Lee, Seung H., Sharma, Jai G., Doval, Dinesh C., Malhotra, Bansi D.

“…We report results of the studies relating to the fabrication of a paper based sensor comprising of poly (3,4-ethylenedioxythiophene):poly(styrenesulfonate)…”
Get full text

Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer by Talwar, Vineet, Raina, Shubhra, Goel, Varun, Dash, Prasanta, Doval, Dinesh

“…Background & objectives: Gallbladder (GBC) is an aggressive form of cancer and most patients present with advanced unresectable disease due to lack of early…”
Get full text

Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial by Gligorov, Joseph, Dr, Doval, Dinesh, MD, Bines, José, MD, Alba, Emilio, Prof, Cortes, Paulo, MD, Pierga, Jean-Yves, Prof, Gupta, Vineet, MD, Costa, Rômulo, MD, Srock, Stefanie, MD, de Ducla, Sabine, DEA, Freudensprung, Ulrich, MSc, Mustacchi, Giorgio, Prof

“…Summary Background Longer duration of first-line chemotherapy for patients with metastatic breast cancer is associated with prolonged overall survival and…”
Get full text

Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer by Bajaj, Rajat, Tripathi, Rupal, Sridhar, T S, Korlimarla, Aruna, Choudhury, Kumardeep Dutta, Suryavanshi, Moushumi, Mehta, Anurag, Doval, Dinesh Chandra

“…The study assessed the epigenetic regulation and the role of microRNA (miR) expression in locally advanced triple negative breast cancers (TNBC) and comparison…”
Get full text

Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma by NOSOV, Dmitry A, ESTEVES, Brooke, LIPATOV, Oleg N, LYULKO, Alexei A, ANISCHENKO, A. A, CHACKO, Raju T, DOVAL, Dinesh C, STRAHS, Andrew, SLICHENMYER, William J, BHARGAVA, Pankaj

“…The antitumor activity and safety of tivozanib, which is a potent and selective vascular endothelial growth factor receptor-1, -2, and -3 inhibitor, was…”
Get full text

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer by GOMEZ, Henry L, DOVAL, Dinesh C, CASEY, Michelle A, BERGER, Mark S, STEIN, Steven H, SLEDGE, George W, CHAVEZ, Miguel A, ANG, Peter C. S, AZIZ, Zeba, NAG, Shona, NG, Christina, FRANCO, Sandra X, CHOW, Louis W. C, ARBUSHITES, Michael C

“…This study (EGF20009) assessed the efficacy and tolerability of two lapatinib administration schedules as first-line monotherapy in women with ErbB2-amplified…”
Get full text

Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective by Bhattacharyya, Gouri Shankar, Doval, Dinesh C, Desai, Chirag J, Chaturvedi, Harit, Sharma, Sanjay, Somashekhar, S P

“…The prevalence and mortality of breast cancer is increasing in Asian countries, including India. With advances in medical technology leading to better…”
Get full text

Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer by Jain, Parveen, Doval, Dinesh Chandra, Batra, Ullas, Goyal, Pankaj, Bothra, Sneha Jatan, Agarwal, Chaturbhuj, Choudhary, Dutta Kumardeep, Yadav, Abhishek, Koyalla, Venkata Pradeep Babu, Sharma, Mansi, Dash, Prashanta, Talwar, Vineet

“…To investigate Ki-67 index with regard to its ability to predict achievement of pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) in breast…”
Get full text

Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population by Sinha, Rupal, Hussain, Showket, Mehrotra, Ravi, Kumar, R Suresh, Kumar, Kapil, Pande, Pankaj, Doval, Dinesh Chandra, Basir, Seemi Farhat, Bharadwaj, Mausumi

“…Colorectal cancer (CRC) development involves underlying modifications at genetic/epigenetic level. This study evaluated the role of Kras gene mutation and…”
Get full text

Colonic polyp-rare site of metastasis from primary lung carcinoma: Clinical presentations and outcome by Agrawal, Chaturbhuj, Goyal, Pankaj, Jain, Praveen, Domadia, Kshitij, Redhu, Pallavi, Doval, Dinesh

“…Although majority of lung cancers have distant metastasis at the time of initial diagnosis, colonic metastases are extremely rare. This report presents a rare…”
Get full text

The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin by Chandra Doval, Dinesh, Mehta, Anurag, Somashekhar, S.P., Gunda, Aparna, Singh, Gurpreet, Bal, Amanjit, Khare, Siddhant, Prakash V Serkad, Chandra, Adinarayan, Manjula, Krishnamoorthy, Naveen, Vijay, Devanhalli Govinda, Anantakrishnan, Radha, Bhattacharyya, G.S., Bakre, Manjiri M.

“…Accurate recurrence risk assessment in hormone receptor positive, HER2/neu negative breast cancer is critical to plan precise therapy. CanAssist Breast (CAB)…”
Get full text

Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer by Rajappa, Senthil, Joshi, Ashish, Doval, Dinesh C, Batra, Ullas, Rajendranath, Rejiv, Deo, Avinash, Biswas, Ghanshyam, Bajpai, Peush, Tilak, T V S, Kane, Sriram, Kumar, Kishore, Kumar, Manish, Talele, Avinash D, Devde, Prakash, Gupta, Ashutosh, Joshi, Nisarg, Sejpal, Jaykumar, Bunger, Deepak, Khan, Mujtaba

“…The management of breast cancer with advanced disease or metastasis is a common problem in India and other countries. A panel of 13 oncology experts…”
Get full text

Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective by Vaid, Ashok K, Gupta, Sudeep, Doval, Dinesh C, Agarwal, Shyam, Nag, Shona, Patil, Poonam, Goswami, Chanchal, Ostwal, Vikas, Bhagat, Sagar, Patil, Saiprasad, Barkate, Hanmant

“…Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and feared side effects in cancer patients undergoing chemotherapy. Scientific…”
Get full text

Treatment conundrums in osteosarcoma of the breast: Case report of two cases from a tertiary care cancer center in India by Chandra Doval, Dinesh, Tayal, Juhi, Dutta Choudhary, Kumardeep, Goyal, Pankaj, Gupta, Gurudutt, Pasricha, Sunil

“…Extraosseous sarcoma of the breast is an infrequent entity and a harbinger of poor prognosis. Histogenesis of this tumor is uncertain, and it can arise both in…”
Get full text

Adjuvant chemotherapy in uterine carcinosarcoma: Comparison of a doublet and a triplet chemotherapeutic regimen by Maheshwari, Udip, Rajappa, Suhas, Talwar, Vineet, Goel, Varun, Dash, Prasanta, Sharma, Manish, Goyal, Pankaj, Jain, Parveen, B Koyyala, Venkata, Doval, Dinesh

“…Background: Uterine carcinosarcoma (UCS) is a rare and aggressive malignancy, and there are no existing standard guidelines for adjuvant therapy. Doublet…”
Get full text

Shared Decision-Making and Medicolegal Aspects: Delivering High-Quality Cancer Care in India by Doval, Dinesh C, Kumar, Prabhash, Talwar, Vineet, Vaid, Ashok K, Desai, Chirag, Ostwal, Vikas, Dattatreya, Palanki S, Agarwal, Vijay, Saxena, Vaibhav

“…It is often difficult for people with cancer to make decisions for their care. The aim of this review is to understand the importance of shared decisionmaking…”
Get full text

Efficacy and tolerability of nimotuzumab in combination with chemotherapy in recurrent and metastatic squamous cell carcinoma of head and neck at a cancer center in Northern India by Yadav, Abhishek, Goyal, Pankaj, Agrawal, Chaturbhuj, Bothra, Sneha, Jain, Parveen, Choudhury, Kumardeep, Gupta, Sunil, Sharma, Manish, Bajaj, Rajat, Upadhyay, Amitabh, Dash, Prashanta, Doval, Dinesh

“…Introduction: Squamous cell carcinoma of head and neck (SCCHN) account for approximately 30-33% of all cancer and the median survival for recurrent and…”
Get full text

Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer by IBRAHIM, Nuhad K, SAMUELS, Brian, PAGE, Ray, DOVAL, Dinesh, PATEL, Kirtikumar M, RAO, S. C, MADHAVAN KRISHNAN NAIR, BHAR, Paul, DESAI, Neil, HORTOBAGYI, Gabriel N

“…ABI-007 is a novel nanoparticle, albumin-bound paclitaxel that is free of solvents. This multicenter phase II study was designed to evaluate the efficacy and…”
Get full text

Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma by Doval, Dinesh, Azam, Saud, Sinha, Rupal, Batra, Ullas, Mehta, Anurag

“…Background: The present study observed the expression levels of epidermal growth factor receptor (EGFR), p53, Bcl2, vascular endothelial growth factor (VEGF),…”
Get full text

A randomized, double-blind, placebo-controlled, phase II study of oral talactoferrin in combination with carboplatin and paclitaxel in previously untreated locally advanced or metastatic non-small cell lung cancer by Digumarti, Raghunadharao, Wang, Yenyun, Raman, Ganapathi, Doval, Dinesh C, Advani, Suresh H, Julka, Pramod K, Parikh, Purvish M, Patil, Shekhar, Nag, Shona, Madhavan, Jayaprakash, Bapna, Ajay, Ranade, Annantbhushan A, Varadhachary, Atul, Malik, Rajesh

“…The aim of the study is to investigate the activity and safety of oral talactoferrin (TLF) plus carboplatin and paclitaxel (C/P) in patients with previously…”
Get more information